1. Generics Bulletin

Teva Fails Over UK Fostair

Court Refuses To Strike Out Chiesi’s Infringement Claims

 
• By Dave Wallace

Following the principle that a generics firm should “clear the way” and resolve issues of patent validity and infringement ahead of launch, Teva has been denied a request to stay or strike out UK infringement claims brought by Chiesi over its Fostair respiratory brand.

Snow_Plough
Teva fell foul of the principle that it should “clear the way” • Source: Shutterstock

Teva has failed to secure a stay of infringement claims brought against it by Chiesi in UK litigation over the originator’s Fostair (beclomethasone/formoterol) respiratory brand.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legal & IP

More from Generics Bulletin